A Metabolic Change towards Fermentation Drives Cancer Cachexia in Myotubes

نویسندگان

چکیده

Cachexia is a disorder associated with several pathologies, including cancer. In this paper, we describe how cachexia induced in myotubes by metabolic shift towards fermentation, and the block of modification prevents onset cachectic phenotype. Cachectic myotubes, obtained treatment conditioned medium from murine colon carcinoma cells CT26, show increased glucose uptake, decreased oxygen consumption, altered mitochondria, lactate production. Interestingly, glycolysis 2-deoxy-glucose or dehydrogenase inhibition oxamate induction cachexia, thus suggesting that change greatly involved activation. The induces positive effects also where mitochondrial membrane potential pyruvate activity became similar to control myotubes. Moreover, treated interleukin-6, phenotype fermentative metabolism, features. same results have been achieved treating media human HCT116 pancreatic MIAPaCa-2 cancer cell lines, showing what has observed murine-conditioned wide phenomenon. These findings demonstrate linked formation impedes highlights as possible new tool for counteracting pathology.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Metabolic signatures imaged in cancer-induced cachexia.

Cancer-induced cachexia is a complex and poorly understood life-threatening syndrome that is characterized by progressive weight loss due to metabolic alterations, depletion of lipid stores, and severe loss of skeletal muscle protein. Gaining the ability to noninvasively image the presence or onset of cachexia is important to better treat this condition, to improve the design and optimization o...

متن کامل

L-carnitine and cancer cachexia. I. L-carnitine distribution and metabolic disorders in cancer cachexia.

Cancer cachexia (CC), a progressive loss of body mass, is associated with decreased energy production. Abnormally low levels of L-carnitine (LC) in skeletal muscle means that mitochondrial β-oxidation of long-chain fatty acids (LCFA) does not occur efficiently in patients with CC. We assessed the influence of CC on LC distribution and the effects of parenteral lipid emulsions on plasma LC level...

متن کامل

Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia

BACKGROUND Aberrant energy metabolism is a hallmark of cancer. To fulfill the increased energy requirements, tumor cells secrete cytokines/factors inducing muscle and fat degradation in cancer patients, a condition known as cancer cachexia. It accounts for nearly 20% of all cancer-related deaths. However, the mechanistic basis of cancer cachexia and therapies targeting cancer cachexia thus far ...

متن کامل

Cachexia in Cancer Patients

Cancer is a leading cause of death worldwide [1]. Besides, overall survival of cancer patients is negatively affected by the presence of comorbidities. In this context, more than one-half of all cancer patients suffer from cachexia. Cachexia is a debilitating condition with high incidence in cancer patients and may lead to delayed, missed, or decreased treatments [2]. Cancer cachexia (CC) has b...

متن کامل

Cancer Cachexia

Cancer anorexia-cachexia (CACS) is defined as a multifactorial syndrome characterized by ongoing loss of skeletal muscle mass that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment [1]. Cancer cachexia occurs across a continuum, varying in severity and stage; according to new classification we have pre-cachexia (early clinical signs of c...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Biomedicines

سال: 2021

ISSN: ['2227-9059']

DOI: https://doi.org/10.3390/biomedicines9060698